Memory Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financi...(e - (396) ...),Health

---------- ---------- ---------- ----------

Net loss $ (9,556) $ (14,727) $ (35,285) $ (31,107)

========== ========== ========== ==========

Basic and diluted net

loss per share of

common stock $ (0.13) $ (0.23) $ (0.49) $ (0.70)

========== ========== ========== ==========

Basic and diluted

weighted average

number of shares of

common stock

outstanding 72,645,081 63,831,072 71,874,757 44,334,129

MEMORY PHARMACEUTICALS CORP.

CONDENSED BALANCE SHEETS

(in thousands)

(unaudited)

December 31, 2007 December 31, 2006

----------------- -----------------

ASSETS

Cash, cash equivalents and

marketable securities $ 38,201 $ 51,323

Other current assets 1,417 1,397

Restricted cash 505 509

Deferred financing costs, net 519 -

Property and equipment, net 5,868 7,413

----------------- -----------------

Total assets $ 46,510 $ 60,642

================= =================

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities

(excluding deferred revenue) $ 8,789 $ 7,664

Warrant liability - 8,724

Equipme
'/>"/>